Eli Lilly & Co
LLY· NYSE
Released Aug 7, 2025, before the open
10-Q filed Aug 7, 2025, 38 days after period end · 0000059478-25-000204
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $15.56B | $11.30B | $8.31B | $6.49B |
| Net Income | $5.66B | $2.97B | $1.76B | $952.50M |
| EPS Diluted |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $6.29 |
| $3.28 |
| $1.95 |
| $1.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.